Sep 30, 2020

Featuring an interview with Dr Jeffrey E Lancet about recent data with induction and maintenance therapy for acute myeloid leukemia, including the following topics:

• Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia — Jeffrey E Lancet, MD (00:00)
• Case: A man in his late 60s with secondary AML,...

Sep 29, 2020

Proceedings from the eleventh in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Robert Dreicer, Ms Kara M Olivier, Ms Victoria Sinibaldi and Dr Matthew R Smith.

• Introduction (00:00)
• Overview of prostate cancer treatment (3:25)
• Management of M0...

Sep 29, 2020

Proceedings from the eighth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Arjun Balar, Ms Anastassia Daskalova, Dr Peter H O’Donnell and Ms Susan K Roethke.

• Introduction (00:00)
• Overview of Urothelial Bladder Cancer (UBC)...

Sep 25, 2020

Featuring an interview with Dr Srdan Verstovsek about recently published and emerging research in the management of myeloproliferative neoplasms, including the following topics:

• Management of myeloproliferative neoplasms — Srdan Verstovsek, MD, PhD (00:00)
• Case: A woman in her early 50s with myelofibrosis (MF) and...

Sep 24, 2020

Proceedings from a webinar on acute myeloid leukemia with Dr Eytan Stein covering the following topics:

• Introduction (00:00)
• Bcl-2 inhibition as a rational therapeutic strategy (1:02)
• FLT3 Inhibitors in the Up-Front and Recurrent Settings (24:00)
• IDH inhibitors in the Up-Front and Recurrent Settings (47:57)